Buys
Open market- Shares
- Avg price
- Total value
Matt Zuga - CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- CFO & Chief Business Officer
- Issuer symbol
- ABOS on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
Matt Zuga - trading volume in the past year for Acumen Pharmaceuticals, Inc.
Sells
Open market- Shares
- -25,953
- Avg price
- $1.91
- Total value
- -$49,556
Net
Past year- Shares
- -25,953
- Share %
- -100%
- Total value
- -$49,556
Holdings reported by Matt Zuga for Acumen Pharmaceuticals, Inc.
Form 4 holding
CFO & Chief Business Officer
Acumen Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 304,924
- Estimated value
- $567,158
- Report date
- 22 Jan 2026
- Price
- $1.86
- Ownership
- Direct
Form 4 holding
CFO & Chief Business Officer
Acumen Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 148,700
- Estimated value
- Report date
- 16 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Matt Zuga for Acumen Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.